Chatenet D - Search Results

1

Peptide modification results in the formation of a dimer with a 60-fold enhanced antimicrobial activity.

Thamri A, Létourneau M, Djoboulian A, Chatenet D, Déziel E, Castonguay A, Perreault J. Thamri A, et al. Among authors: chatenet d. PLoS One. 2017 Mar 15;12(3):e0173783. doi: 10.1371/journal.pone.0173783. eCollection 2017. PLoS One. 2017. PMID: 28296935 Free PMC article.

2

Characterization of the adrenomedullin receptor acting as the target of a new radiopharmaceutical biomolecule for lung imaging.

Fu Y, Létourneau M, Nguyen QT, Chatenet D, Dupuis J, Fournier A. Fu Y, et al. Among authors: chatenet d. Eur J Pharmacol. 2009 Sep 1;617(1-3):118-23. doi: 10.1016/j.ejphar.2009.06.031. Epub 2009 Jun 24. Eur J Pharmacol. 2009. PMID: 19559019

3

Design and in vitro characterization of PAC1/VPAC1-selective agonists with potent neuroprotective effects.

Doan ND, Bourgault S, Dejda A, Létourneau M, Detheux M, Vaudry D, Vaudry H, Chatenet D, Fournier A. Doan ND, et al. Among authors: chatenet d. Biochem Pharmacol. 2011 Feb 15;81(4):552-61. doi: 10.1016/j.bcp.2010.11.015. Epub 2010 Nov 27. Biochem Pharmacol. 2011. PMID: 21114961

4

Characterization of iodinated adrenomedullin derivatives suitable for lung nuclear medicine.

Fu Y, Létourneau M, Chatenet D, Dupuis J, Fournier A. Fu Y, et al. Among authors: chatenet d. Nucl Med Biol. 2011 Aug;38(6):867-74. doi: 10.1016/j.nucmedbio.2011.01.011. Epub 2011 Apr 21. Nucl Med Biol. 2011. PMID: 21843783

5

Biochemical and pharmacological characterization of nuclear urotensin-II binding sites in rat heart.

Doan ND, Nguyen TT, Létourneau M, Turcotte K, Fournier A, Chatenet D. Doan ND, et al. Among authors: chatenet d. Br J Pharmacol. 2012 May;166(1):243-57. doi: 10.1111/j.1476-5381.2011.01710.x. Br J Pharmacol. 2012. PMID: 22044114 Free PMC article.

6

Urocontrin, a novel UT receptor ligand with a unique pharmacological profile.

Chatenet D, Nguyen QT, Létourneau M, Dupuis J, Fournier A. Chatenet D, et al. Biochem Pharmacol. 2012 Mar 1;83(5):608-15. doi: 10.1016/j.bcp.2011.12.009. Epub 2011 Dec 16. Biochem Pharmacol. 2012. PMID: 22197588

7

Presence of urotensin-II receptors at the cell nucleus: specific tissue distribution and hypoxia-induced modulation.

Nguyen TT, Létourneau M, Chatenet D, Fournier A. Nguyen TT, et al. Among authors: chatenet d. Int J Biochem Cell Biol. 2012 Apr;44(4):639-47. doi: 10.1016/j.biocel.2011.12.022. Epub 2012 Jan 9. Int J Biochem Cell Biol. 2012. PMID: 22245063

8

Receptor-independent cellular uptake of pituitary adenylate cyclase-activating polypeptide.

Doan ND, Chatenet D, Létourneau M, Vaudry H, Vaudry D, Fournier A. Doan ND, et al. Among authors: chatenet d. Biochim Biophys Acta. 2012 Apr;1823(4):940-9. doi: 10.1016/j.bbamcr.2012.02.001. Epub 2012 Feb 9. Biochim Biophys Acta. 2012. PMID: 22343001 Free article.

9

Cardiotoxin-I: an unexpectedly potent insulinotropic agent.

Nguyen TT, Folch B, Létourneau M, Vaudry D, Truong NH, Doucet N, Chatenet D, Fournier A. Nguyen TT, et al. Among authors: chatenet d. Chembiochem. 2012 Aug 13;13(12):1805-12. doi: 10.1002/cbic.201200081. Epub 2012 Jul 16. Chembiochem. 2012. PMID: 22807058

10

Design and characterization of novel cell-penetrating peptides from pituitary adenylate cyclase-activating polypeptide.

Doan ND, Létourneau M, Vaudry D, Doucet N, Folch B, Vaudry H, Fournier A, Chatenet D. Doan ND, et al. Among authors: chatenet d. J Control Release. 2012 Oct 28;163(2):256-65. doi: 10.1016/j.jconrel.2012.08.021. Epub 2012 Aug 24. J Control Release. 2012. PMID: 22922050

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

76 results

Search Page

Filters